Skip to content

Veracyte

US · VCYT #2330 by market cap Listed 1970
25.13 +0.09 +0.36%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    William Blair Maintains Veracyte(VCYT.US) With Buy Rating
    Market Newswire · 2026/9/16
  • Rating change
    Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $66
    Market Newswire · 2026/7/31
  • Stephens Maintains Veracyte(VCYT.US) With Buy Rating, Cuts Target Price to $40
    Market Newswire · 2026/11/11
  • UBS Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $65
    Market Newswire · 2026/9/9
  • Rating change
    Jefferies Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $70
    Market Newswire · 2026/7/9
  • Rating change
    Piper Sandler Initiates Veracyte(VCYT.US) With Buy Rating, Announces Target Price $66
    Market Newswire · 2026/7/15
  • Rating change
    CCORF Maintains Veracyte(VCYT.US) With Hold Rating, Raises Target Price to $60
    Market Newswire · 2026/7/14
  • Rating change
    Needham Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $69
    Market Newswire · 2026/7/31
  • Rating change
    William Blair Initiates Veracyte(VCYT.US) With Buy Rating
    Market Newswire · 2026/7/31
  • Rating change
    CCORF Maintains Veracyte(VCYT.US) With Hold Rating, Cuts Target Price to $50
    Market Newswire · 2026/8/3
  • Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $54
    Market Newswire · 2026/11/5
  • Rating change
    Needham Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $69
    Market Newswire · 2026/9/15
  • Rating change
    Craig-Hallum Maintains Veracyte(VCYT.US) With Buy Rating
    Market Newswire · 2026/9/16
  • Rating change
    Freedom Capital Markets Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $66
    Market Newswire · 2026/9/15
  • Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Cuts Target Price to $30
    Market Newswire · 2026/11/10
  • Rating change
    Morgan Stanley Maintains Veracyte(VCYT.US) With Sell Rating, Cuts Target Price to $44
    Market Newswire · 2026/8/4
  • Rating change
    Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Cuts Target Price to $54
    Market Newswire · 2026/8/4
  • UBS Maintains Veracyte(VCYT.US) With Buy Rating, Cuts Target Price to $35
    Market Newswire · 2026/11/9
  • Rating change
    Stephens Initiates Veracyte(VCYT.US) With Buy Rating, Announces Target Price $55
    Market Newswire · 2026/8/4
  • Rating change
    Morgan Stanley Maintains Veracyte(VCYT.US) With Sell Rating, Raises Target Price to $47
    Market Newswire · 2026/7/9
  • Rating change
    Needham Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $48
    Market Newswire · 2026/5/28
  • Rating change
    Guggenheim Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $65
    Market Newswire · 2026/6/29
  • Rating change
    Needham Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $57
    Market Newswire · 2026/6/1
  • Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $54
    Market Newswire · 2026/9/17

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Veracyte discussion 0 comments

Add a comment